Abstract P3-07-42: Predicting Outcome and Benefit to First-Line Bevacizumab in Advanced/metastatic Hormone Receptor (Hr)+/her2-Negative Breast Cancer (BC) Treated with Endocrine Therapy: A Correlative Science Study from the LEA Phase III Clinical Trial (GEICAM/2006-11_GBG 051)
Cancer Research（2016）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined